— Know what they know.
Not Investment Advice
Also trades as: 0J4V.L (LSE) · $vol 0M

HRTX NASDAQ

Heron Therapeutics, Inc.
1W: +18.1% 1M: +11.1% 3M: -19.9% YTD: -72.4% 1Y: -72.2% 3Y: -64.9% 5Y: -97.2%
$0.35
-0.01 (-2.33%)
 
Weekly Expected Move ±12.2%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 54 · $65.8M mcap · 135M float · 2.29% daily turnover · Short 60% of daily vol

Supply Chain Overview

13 relationships
13
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2023-02-22
Earliest Filing
2025-08-28
Latest Filing
investor: 8 partner: 4 supplier: 1

Counterparties (Filed by HRTX)

13 relationships

Companies named in HRTX's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
USEF HCG Fenton LLC — partner Landlord for the Company's new corporate headquarters lease. 2025-08-28 View
Computershare Trust Company, N.A. — partner Rights agent for the Tax Benefit Preservation Plan 2025-08-15 View
Patheon Austria GmbH & Co KG — supplier Agreement for manufacturing and supply of specific products 2025-08-12 View
Thermo Fisher Scientific Inc. TMO partner Named party in Framework Agreement for unspecified purposes 2025-08-12 View
Rubric Capital Management LP — investor Entered into a Cooperation Agreement to appoint a director and participated in refinancing transactions including note p 2025-08-12 View
Leerink Partners — investor Served as exclusive financial advisor and placement agent. 2025-08-08 View
DLA Piper LLP (US) — partner Served as legal advisor to Heron Therapeutics. 2025-08-08 View
Rubric Capital Management LP — investor Purchaser of common stock and pre-funded warrants in a private placement. 2023-07-24 View
Velan Capital — investor Purchaser of common stock and pre-funded warrants in a private placement. 2023-07-24 View
Clearline Capital — investor Purchaser of common stock and pre-funded warrants in a private placement. 2023-07-24 View
Hercules Capital, Inc. HCXY investor Purchaser of common stock and pre-funded warrants in a private placement. 2023-07-24 View
Rubric Capital Management LP — investor Entered into a Cooperation Agreement with Heron Therapeutics regarding Board composition changes. 2023-02-22 View
Velan Capital Investment Management LP — investor Entered into a Cooperation Agreement with Heron Therapeutics regarding Board composition changes. 2023-02-22 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-29 Material Agreement; Exhibits Agreement View
2026-08-14 Material Agreement; Exhibits Agreement View
2026-08-10 Earnings Release; Exhibits View
2026-06-25 Delisting Notice; Exhibits View
2026-06-16 Shareholder Vote View
2026-06-02 Other Events; Exhibits View
2026-04-06 Officer/Director Change; Exhibits View
2026-02-26 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2026-01-09 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-11-04 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-10-29 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
2025-10-15 Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits View
2025-08-28 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-08-15 Entry into Material Definitive Agreement; Material Modification to Rights of Security Holders; Amend Agreement View
2025-08-12 Entry into Material Definitive Agreement Agreement View
2025-08-12 Entry into Material Definitive Agreement; Amendments to Articles of Incorporation or Bylaws; Other E Agreement View
2025-08-08 Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Creation of Agreement View
2025-06-18 Submission of Matters to a Vote of Security Holders View
2025-05-06 Other Events; Financial Statements and Exhibits View
2025-05-06 Results of Operations and Financial Condition; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms